A genetic technique called allelic discrimination — which detects a specific variant of the F12 gene — might…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Researchers have developed a new rat model of hereditary angioedema (HAE) that more closely mimics the swelling episodes experienced…
In a new study, researchers provide recommendations for when to consider a diagnosis of hereditary angioedema (HAE) for patients…
Haegarda Safe, Effective in the Long-term for Preventing Hereditary Angioedema Attacks, Study Finds
Haegarda, a concentrated form of C1 inhibitor (C1-INH), is safe and effectively helps to prevent hereditary angioedema attacks in the…
Some mutations in the SERPING1 gene that cause hereditary angioedema (HAE) result in an abnormal form of the C1 inhibitor (C1-INH)…
Physicians in Canada need better education about the multiple biological assays used to diagnose hereditary angioedema caused by C1 inhibitor…